Adhesion Barrier Market by Product (Synthetic [Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol {PEG}], Natural [Collagen- & Protein-Based, Fibrin-Based]), by Formulation (Film, Gel, Liquid), by Application (Gynecological Surgeries, General/Abdominal Surgeries, Orthopedic Surgeries, Cardiovascular Surgeries, Neurological Surgeries, Urological Surgeries, Reconstructive Surgeries), by Geography (U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, China, India) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023

NEW YORK, March 14, 2019 (GLOBE NEWSWIRE) -- Growth in geriatric population, coupled with the rising incidence of chronic diseases, is resulting in an increased number of surgeries across the world. Along with advancements in healthcare technology, these have become the major growth factors for the global adhesion barrier market. Valued at $541.3 million in 2017, the domain is expected to generate revenue of $833.1 million by 2023, progressing at a CAGR of 7.5% during forecast period (2018–2023).

Request to get the sample pages of the report:

Adhesion barrier is a physical barrier applied between the layers of tissue during surgery, so that operated-upon tissues do not overlap with other tissues and organs while healing. Once the surgical site heals, the barrier itself is dissolved and absorbed by the body. The adhesion barrier market has been segmented by product, formulation, application, and geography. Adhesion barriers are available in two product types: synthetic and natural. Of the two, synthetic adhesion barriers were preferable during the historical period 2013–2017, owing to their higher flexibility and bioabsorbility. In 2017, these made a revenue contribution of 67.2% to the market.

In recent years, due to the increase in health issues across the world, the number of surgeries, such as abdominal and gynecological surgeries, has risen considerably. Gel, film, and liquid-based adhesion barriers are generally used in these surgeries. With the rise in the number of surgeries performed around the world, the demand for these products has also increased, hence driving the adhesion barrier market.

According to a report published by the World Health Organization (WHO) in 2016, approximately 266–360 million surgeries were performed in 2012 globally. Due to the increasing incidents of chronic diseases, such as arthritis and cardiovascular diseases, which require surgical intervention as a therapeutic procedure, the demand for adhesion barriers has increased. This is expected to drive the growth of adhesion barrier market in the forecast period.

Browse report overview with 189 tables and 62 figures spread through 195 pages and detailed TOC on "Adhesion Barrier Market" at:

Moreover, with rising awareness about diseases and surgeries, the assurance of quality and performance of the devices used in medical procedures is being demanded by patients. The United States Food and Drug Administration (USFDA) defines the resorbable adhesion barrier as a “significant risk device” in its 21 Code for Regulations (CFR) 812.3(m)(4). Therefore, the device is required to undergo several evaluative procedures before final approval, which often consumes too much time. But, with advancements in technology aiding the development of safer equipment, the adhesion barrier market is expected to witness notable growth in the near future.

Key players of the adhesion barrier market, such as Johnson & Johnson, MAST Biosurgery AG, and Anika Therapeutics Inc., have witnessed significant prosperity due to the progress in the domain in recent years. With increased revenue, they are spending more on the research and development of new products to broaden their portfolio. In a recent industry development of 2017, Actamax Surgical Materials LLC received the USFDA approval to put its sprayable and bioabsorbable Actamax adhesion barrier through clinical trials.

Make enquiry before buying the report:

Thus, it is clear that the sector will continue to prosper during the forecast period owing to the rise in surgeries, increase in awareness about surgical and post-surgical risks, and advancements in the adhesion barrier technology.

More Related Reports by P&S Intelligence

Chronic Pain Treatment Market

The chronic pain treatment market is expected to witness the fastest growth in the APAC region. This can be mainly attributed to the high prevalence of chronic pain among people in the region. Among all age groups, the elderly are the most susceptible to chronic conditions, such as arthritis, neuropathic disorders, and back pain. According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), the number of aged people in the region is expected to increase twofold, from 535 million in 2015 to 1.3 billion by 2050.

Middle East Dermal Fillers Market

Historically, in terms of size, Saudi Arabia has been leading the dermal fillers industry in the Middle East. This can be attributed to growing aging population, increasing demand for cosmetic procedures, and availability of skilled practitioners for dermal filler procedures in the country. According to UNDESA, the proportion of people in Saudi Arabia aged 60 years and above is predicted to be 25% of the total population of 40 million by the end of 2050, leading to the growth of the market in Saudi Arabia, and thereby, maintaining its leading position in the Middle East.

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.


P&S Intelligence

Toll-free: +1-888-778-7886 (USA/Canada)

International: +1-347-960-6455



Connect with us: LinkedIn | Twitter | Google + | Facebook